Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1953 1
1954 1
1957 1
1958 1
1962 3
1964 1
1966 2
1968 2
1969 2
1970 2
1971 2
1972 1
1973 1
1974 2
1975 3
1977 3
1979 1
1980 3
1981 2
1982 2
1983 2
1984 1
1986 2
1987 1
1989 3
1990 1
1992 1
1994 1
1995 1
1996 2
1997 1
1998 1
1999 2
2000 1
2001 3
2002 5
2003 2
2004 5
2005 9
2006 9
2007 13
2008 19
2009 15
2010 20
2011 43
2012 53
2013 68
2014 67
2015 86
2016 61
2017 61
2018 63
2019 76
2020 79
2021 78
2022 70
2023 74
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

955 results

Results by year

Filters applied: . Clear all
Page 1
Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease.
Park S, Park CW, Eom JH, Jo MY, Hur HJ, Choi SK, Lee JS, Nam ST, Jo KS, Oh YW, Lee J, Kim S, Kim DH, Park CY, Kim SJ, Lee HY, Cho MS, Kim DS, Kim DW. Park S, et al. Among authors: jo ks. Cell Stem Cell. 2024 Jan 4;31(1):25-38.e8. doi: 10.1016/j.stem.2023.11.009. Epub 2023 Dec 11. Cell Stem Cell. 2024. PMID: 38086390 Free article.
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea.
Mok J, Lee M, Kim DK, Kim JS, Jhun BW, Jo KW, Jeon D, Lee T, Lee JY, Park JS, Lee SH, Kang YA, Lee JK, Kwak N, Ahn JH, Shim TS, Kim SY, Kim S, Kim K, Seok KH, Yoon S, Kim YR, Kim J, Yim D, Hahn S, Cho SN, Yim JJ; MDR-END investigators. Mok J, et al. Among authors: jo kw. Lancet. 2022 Oct 29;400(10362):1522-1530. doi: 10.1016/S0140-6736(22)01883-9. Lancet. 2022. PMID: 36522208 Clinical Trial.
Non-clinical pharmacokinetic behavior of ginsenosides.
Won HJ, Kim HI, Park T, Kim H, Jo K, Jeon H, Ha SJ, Hyun JM, Jeong A, Kim JS, Park YJ, Eo YH, Lee J. Won HJ, et al. Among authors: jo k. J Ginseng Res. 2019 Jul;43(3):354-360. doi: 10.1016/j.jgr.2018.06.001. Epub 2018 Jun 18. J Ginseng Res. 2019. PMID: 31308806 Free PMC article. Review.
Exciton-Photonics: From Fundamental Science to Applications.
Anantharaman SB, Jo K, Jariwala D. Anantharaman SB, et al. Among authors: jo k. ACS Nano. 2021 Aug 24;15(8):12628-12654. doi: 10.1021/acsnano.1c02204. Epub 2021 Jul 26. ACS Nano. 2021. PMID: 34310122 Review.
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension.
Sindi HA, Russomanno G, Satta S, Abdul-Salam VB, Jo KB, Qazi-Chaudhry B, Ainscough AJ, Szulcek R, Jan Bogaard H, Morgan CC, Pullamsetti SS, Alzaydi MM, Rhodes CJ, Piva R, Eichstaedt CA, Grünig E, Wilkins MR, Wojciak-Stothard B. Sindi HA, et al. Among authors: jo kb. Nat Commun. 2020 Mar 4;11(1):1185. doi: 10.1038/s41467-020-14966-x. Nat Commun. 2020. PMID: 32132543 Free PMC article.
Beyond the survey, to the ideal therapy for Asian.
Jo KJ, Im JP. Jo KJ, et al. Intest Res. 2023 Jul;21(3):280-282. doi: 10.5217/ir.2023.00075. Epub 2023 Jul 27. Intest Res. 2023. PMID: 37533263 Free PMC article. No abstract available.
DNA Visualization Using Fluorescent Proteins.
Jin X, Kim YT, Jo K. Jin X, et al. Among authors: jo k. Methods Mol Biol. 2023;2564:223-246. doi: 10.1007/978-1-0716-2667-2_11. Methods Mol Biol. 2023. PMID: 36107345
955 results